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Volume 61, Number 2 Abstracts 5712009. The primary endpoint was access closure time. Secondary outcome
measures included access related costs and evaluation of the short- and
mid-term complications. Evaluationwas performed peri- and post-operatively,
at discharge, at 30 days and at 6 months follow up.
Results: The median access closure time was 12.4 minutes for FST
and 19.9 minutes for Prostar (p < .001). Prostar required a 54% greater pro-
cedure time than FST, mean ratio 1.54 (95% CI 1.25e.90, p < .001) ac-
cording to regression analysis. Adjusted for operator experience the mean
ratio was 1.30 (95% CI 1.09e.55, p ¼ .005) and for patient body mass in-
dex 1.59 (95% CI 1.28e.96, p < .001). The technical failure rate for oper-
ators at proﬁciency level was 5% (2/40) compared with 28% (17/59) for
those at the basic level (p ¼ .003). The proﬁciency level group had a tech-
nical failure rate of 4% (1/26) for FST and 7% (1/14) for Prostar, p ¼ 1.00,
while corresponding rates for the basic level group were 27% (6/22) for
FST and 30% (11/37) for Prostar (p ¼ .84). There was a signiﬁcant differ-
ence in cost in favor of FST, with a median difference of V800 (95% CI
710e927, p < .001).
Conclusions: In aortic endovascular repair FST is a faster and cheaper
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Objective/Background: Intermittent claudication (IC) is associated
with a reduction in physical activity (PA) and a more rapid functional declineleading to a higher mortality rate compared with healthy individuals. Super-
vised exercise therapy (SET) is known to increase the walking capacity of pa-
tients with IC. However, it is unclear whether SET increases PA. The aim of
this study was to investigate the effect of SET on PA levels and ambulatory
activities in patients with IC.
Methods: Patients newly diagnosed with IC were requested to wear
an activity monitor 1 week prior to and 1 week immediately after 3 months
of SET. The primary outcome was the percentage of patients meeting the
minimum recommendations of PA (American College of Sports Medicine
[ACSM]/American Heart Association [AHA] recommendation for public
health of $ 67 metabolic equivalents [METs]/min/day, in bouts of $
10 min) at baseline and after 3 months of SET. Additionally, daily PA level
(METs/min), duration of ambulatory activities, daily number of steps, pain
free walking distance (PFWD), maximal walking distance (MWD), and
Short Form Health Survey (SF-36) health surveys were compared before
and after SET.
Results: Data from 41 participants were available for analysis. A
higher number of participants met the ACSM minimum recommendation
for PA at the 3 month follow up (baseline: 43%; 3 months: 63%; p ¼
.003). Despite signiﬁcant increases in PFWD (baseline: 210 m; 3 months:
390 m; p ¼ .001), MWD (baseline: 373 m; 3 months: 555 m; p ¼ .002)
and physical functioning score (SF-36) following SET, no increase in the
mean daily PA level was found (395 6 220 vs. 411 6 228 METs/min;
p ¼ .43). Furthermore, the total number of steps and time spent in ambu-
latory activities did not change following SET.
Conclusion: Three months of SET for IC leads to more patients
meeting the ACSM/AHA public health minimum recommendations for PA.
Assessment of PA could be incorporated as an outcome parameter in future
research comparing different treatment modalities for peripheral arterial disease.
